AMENDMENT TO 4% UNSECURED PROMISSORY NOTE4% Unsecured Promissory Note • February 2nd, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
THIS AMENDMENT TO 4% UNSECURED PROMISSORY NOTE (this “Amendment”) is entered into and made effective as of January, 31, 2024 (the “Effective Date”), by and between VITRO BIOPHARMA, INC., a Nevada corporation (the “Company”), and JIM MUSICK, an individual (the “Holder”).
AMENDMENT TO 6% UNSECURED PROMISSORY NOTE6% Unsecured Promissory Note • February 2nd, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
THIS AMENDMENT TO 6% UNSECURED PROMISSORY NOTE (this “Amendment”) is entered into and made effective as of January 31, 2024 (the “Effective Date”), by and between VITRO BIOPHARMA, INC., a Nevada corporation (the “Company”), and JIM MUSICK, an individual (the “Holder”).
CONSULTING AGREEMENTConsulting Agreement • February 2nd, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
This Consulting Agreement (this “Agreement”) is entered into as of this 16th day of November, 2023 (the “Effective Date”), by and between (1) Alchemy Advisory LLC, a limited liability company organized under the laws of Puerto Rico (the “Consultant”) and located at 144 Hillside Village, Rio Grande, PR 00745, and (2) Vitro Biopharma, Inc., a Nevada corporation (the “Company”) and having its principal place of business at 3200 Cherry Creek Drive South, Suite 720, Denver, Colorado 80209. The Company and Consultant are collectively referred to herein as the “Parties”.
